Kiralj Rudolf, Ferreira Márcia M C
Laboratório de Quimiometria Teórica e Aplicada, Instituto de Química, Universidade Estadual de Campinas, Campinas, SP 13084-971, Brazil.
J Mol Graph Model. 2006 Sep;25(1):126-45. doi: 10.1016/j.jmgm.2005.10.010. Epub 2006 Jan 6.
AcrAB-TolC is the most important multidrug efflux pump system of Gram-negative bacteria, responsible for their resistance to lipophilic and amphiphilic drugs. In this work, a molecular graphics study of the pump components AcrB and TolC, 16 beta-lactam antibiotics and 7 other substrates, as well as of AcrB-substrate complexes, was performed in order to give a mechanistic proposal for the efflux process at molecular level. AcrAB-TolC is a proton-dependent electromechanical device which opens to extrude drugs from the bacterial periplasm and perhaps cytoplasm, by means of a series of structural changes within the complex and its components AcrA, AcrB and TolC. These changes are initiated by protonation and disruption of salt bridges and certain hydrogen bonds, and are followed by conformational changes in which a number of intra- and interchain interactions are rearranged. Molecular properties of beta-lactams accounting for their lipophilicity, shape/conformation and other sterical features, polar/charge group distribution and other electronic properties, and hydrogen bonding potency determine their interaction with polar headpieces of the inner membrane, recognition and binding to receptors of AcrB and TolC. The orientation of the beta-lactam molecular dipoles with respect the efflux system is maintained during the drug efflux. Elongated cylinder-like beta-lactam antibiotics with lipophylic side chains, a significantly negative component of the dipole moment and low hydrogen bonding capacity seem to be good substrates of AcrAB-TolC.
AcrAB-TolC是革兰氏阴性菌中最重要的多药外排泵系统,负责细菌对亲脂性和两亲性药物的耐药性。在本研究中,对泵组件AcrB和TolC、16种β-内酰胺抗生素和7种其他底物以及AcrB-底物复合物进行了分子图形学研究,以便在分子水平上对流出过程提出一个机制建议。AcrAB-TolC是一种质子依赖的机电装置,通过复合物及其组件AcrA、AcrB和TolC内的一系列结构变化,打开通道以将药物从细菌周质甚至可能从细胞质中排出。这些变化由盐桥和某些氢键的质子化和破坏引发,随后是构象变化,其中许多链内和链间相互作用被重新排列。β-内酰胺类药物的分子性质,包括它们的亲脂性、形状/构象和其他空间特征、极性/电荷基团分布和其他电子性质以及氢键能力,决定了它们与内膜极性头部的相互作用、对AcrB和TolC受体的识别和结合。在药物流出过程中,β-内酰胺分子偶极相对于流出系统的方向保持不变。具有亲脂性侧链、偶极矩有显著负成分且氢键能力低的细长圆柱状β-内酰胺抗生素似乎是AcrAB-TolC的良好底物。